ReAlta Life Sciences Raises $20M in Series A3 Financing

29 Apr, 2021

ReAlta Life Sciences Raises $20M in Series A3 Financing
Photo by Artem Zhukov on Unsplash

– ReAlta Life Sciences, Inc. from Norfolk, Virginia closed a $20m Series A3 financing.
– The round was led by Marathon Pharma with participation from existing investors and new, undisclosed investors.
– The company intends to use the funds to advance multiple programs addressing ALI and HIE, including lead candidate RLS-0071, into Phase 2 clinical trials.

Biotechnology Life Science North America Pharmaceutical
Crunchbase icon

Content report

The following text will be sent to our editors: